Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Companion Animal Ear Infection Treatment Market

Companion Animal Ear Infection Treatment Market Size

  • Report ID: GMI8373
  • Published Date: Mar 2024
  • Report Format: PDF

Companion Animal Ear Infection Treatment Market Size

Companion Animal Ear Infection Treatment Market size was valued at USD 648 million in 2023 and is expected to reach USD 1.2 billion by 2032 growing at a CAGR of 6.8% over the analysis period. The market has experienced significant growth driven by rising pet adoption rates and increasing awareness regarding pet health, compounded by the prevalence of infectious diseases.

 

As reported in the Companion Animal Journal, otitis or ear infection, is a widespread concern in veterinary practice, impacting around 15–20% of dogs and 4–7% of cats. This condition presents a significant challenge for veterinarians and pet owners due to its rising prevalence and the complexities involved in its diagnosis and treatment. Thus, the growing companion animal population and the rising incidence of ear infection cases in pets are expected to drive demand for effective treatment options, thereby fuelling market growth in the foreseeable future.

 

Companion animal ear infection treatment involves diagnosing and managing ear infections (otitis) in pets, primarily dogs and cats, as well as other companion animals like rabbits and ferrets. Ear infections in companion animals are mainly caused by bacteria, yeast, parasites, allergies, or other anatomical abnormalities. The treatment involves a combination of topical and/or systemic medications intended to control infection, reduce inflammation, alleviate discomfort, and address underlying causes such as allergies.

 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global companion animal ear infection treatment market was valued at USD 648 million in 2023 and is expected to reach USD 1.2 billion by 2032, driven by rising pet adoption rate and increasing awareness regarding pet health.

Dogs segment held the largest market share of 61.7% in 2023, as dogs are more prone to ear infections compared to other companion animals due to their anatomy and lifestyle factors.

In 2023, North America companion animal ear infection treatment industry held a revenue share of 37.2% and will present lucrative growth avenue through 2032, attributed to a large population of companion animals with higher prevalence of ear infections, alongside the presence of well-established veterinary healthcare infrastructure.

Bayer AG, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Merck & Co., Inc., Nextmune, Penn Veterinary Supply, Inc., Piedmont Animal Health, Inc., Vedco, Inc., Vetnique Labs., Vetoquinol S.A., Virbac S.A., Wedgewood Village Pharmacy, LLC, and Zoetis Inc.

Companion Animal Ear Infection Treatment Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 15
  • Tables & Figures: 385
  • Countries covered: 19
  • Pages: 215
 Download Free Sample